Market News

Russell rotation: YTD market capitalizations swelling for small-caps







Russell Small-Cap Surge

Small-Cap Stocks Shine While Large-Caps Stall

Investors have witnessed a remarkable shift in the equity market dynamics this year, with small-cap stocks like Abercrombie & Fitch (ANF) basking in the limelight of soaring year-to-date market capitalizations. This surge is fueled by a pronounced rotation from the once-dominant large-cap stocks in the U.S. market, such as the S&P 500 and NASDAQ Composite.

The Russell 2000 (RTY) index, the quintessential benchmark for small-cap stocks, has experienced a resurgence, marking a second consecutive week of growth with a 1.5% uptick. However, despite this encouraging momentum, the rally faced some headwinds, tempering the exuberance that had characterized its recent climb.

Notably, small-caps have been attracting significant investor interest, with small-cap funds attracting a hefty $9.9 billion in inflows over the past week, according to Bank of America, citing data from EPFR, marking the second-largest weekly influx on record.

Insmed Leads the Small-Cap Charge

Among the standout performers within the Russell 2000 constituents is Insmed (INSM), a biotech company specializing in rare pulmonary diseases. Insmed has not only witnessed a substantial surge in its stock price but has also seen its market capitalization balloon from $4.3 billion in 2023 to a staggering $11.3 billion in the current year. The stock price of Insmed has surged by a remarkable 145% year-to-date—an impressive turnaround from a nearly 29% loss experienced in late May.

Market Cap Surges for Top 10 IWM Stocks

Delving deeper into the small-cap landscape, the top 10 most valuable stocks in the iShares Russell 2000 ETF (IWM) have witnessed substantial market cap expansions since the beginning of the year:

  • Insmed (INSM) – Market cap: $11.3B – Market cap in 2023: $4.3B
  • FTAI Aviation (FTAI) – Market cap: $10.3B – Market cap in 2023: $4.65B
  • Vaxcyte (PCVX) – Market cap: $8.66B – Market cap in 2023: $5.98B
  • Fabrinet (FN) – Market cap: $8.58B – Market cap in 2023: $6.91B
  • Sprouts (SFM) – Market cap: $8.31B – Market cap in 2023: $4.89B
  • Fluor (FLR) – Market cap: $8.2B – Market cap in 2023: $4.89B
  • Abercrombie & Fitch (ANF) – Market cap: $8.02B – Market cap in 2023: $4.45B
  • Lantheus (LNTH) – Market cap: $8.02B – Market cap in 2023: $4.25B
  • Applied Industrial Technologies (AIT) – Market cap: $8.01B – Market cap in 2023: $4.25B
  • Ensign Group (ENSG) – Market cap: $7.7B – Market cap in 2023: $6.28B
See also  Intel Corporation's Stock Struggles Amidst Earnings Woes The Downfall of Intel's Stock Post-Earnings Revelation

Intel Corporation (INTC), known for its stronghold in the semiconductor industry, recently unveiled a challenging second quarter that has left analysts and investors apprehensive about the company's future performance. The disappointing earnings report, marked by revenue declines, substantial job cuts, and the suspension of dividends, has triggered a cascade of lowered price targets and downgrades, casting a somber shadow over Intel's once-sturdy stock standing.

Insight into Intel's Stock

Based in Santa Clara, California, Intel Corporation (INTC) commands a market capitalization of $80.84 billion within the global semiconductor domain. Specializing in the production of an array of computing products like microprocessors, chipsets, and cutting-edge driver assistance systems for autonomous vehicles, Intel has seen a plummet of 62.2% in its year-to-date stock performance, vastly underperforming the general market.

www.barchart.com The Abrupt Plummet of Intel's Shares Post-Q2 Reveal

Following the recent investor call on August 1, Intel reported lower-than-anticipated Q2 results, issuing a lackluster Q3 forecast. Additionally, the tech giant revealed plans for a sizable reduction in its workforce by over 15% and the halting of dividend payments. Subsequently, Intel's shares nosedived by over 26% in the subsequent trading period.

In Q2, Intel recorded total revenue of $12.8 billion, a slight 1% drop compared to the previous year, missing estimates by $150 million. While the company witnessed a 4% revenue growth in its Products unit, led by robust client computing gains offsetting modest declines in the data center segment, it failed to match the soaring growth experienced by its competitors in this domain.

With the revenue dip year-over-year, the non-GAAP gross margin fell as well, dropping 1.1 percentage points to 38.7%, notably beneath the company's anticipated 43.5% mark. This decline, coupled with a 5% increase in operational expenses, saw the adjusted operating margin shrink to a mere 0.2%, a significant regression from the 3.5% reported in the prior year.

Challenges Ahead: Lunar Lake's Looming Margins and Margin-Recovery Strategies

Intel's woes deepen with the impending release of its Lunar Lake CPU in late Q3, a product lineup that is slated to face margin constraints. The limited adoption of Lunar Lake, influenced by its release timing, poses a significant obstacle to Intel's profit margins, necessitating the company to postpone its 60% margin target until 2026.

On a more hopeful note, Intel is counting on its forthcoming 18A process products, like Panther Lake and Clearwater Forest, due to launch in the latter half of 2025, to revamp its profit margins. However, the benefits from these new products and processes are not expected to materialize until 2026.

Marked by revenue and margin hurdles alongside substantial capital expenses and a hefty $48 billion debt load, Intel has embarked on an aggressive cost-reduction initiative. This involves a 15% slash in its 110,000-strong workforce, a more than 20% decrease in projected 2024 investments in new infrastructure, with spending now ranging between $25 billion and $27 billion.

Intel Faces Investor BacklashIntel's Dive into the Abyss: Investor Backlash After Dividend Suspension

Small-cap ETFs, including (IJR), (VB), (VBR), (SPSM), and (DFAS), further exemplify the growing significance and attractiveness of this segment in the current market environment.